Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00276159 · OUTCOME

Peak Concentrations of 852A

Study of Immune Response Modifier in the Treatment of Hematologic Malignancies · Source last updated 2019-09-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to Week 12

What was measured

Measurement of peak concentrations of 852A to correlate the side effects of tolerability in patients.

Analysis population: Not able to analysis due to sale of agent - unable to perform.

Groups in this outcome

852A Treatment

Patients receiving at least 12 doses of 852A.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
852A Treatment0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2009-12
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
Measurement of peak concentrations of 852A to correlate the side effects of tolerability in patients.
groups
  1. description
    Patients receiving at least 12 doses of 852A.
    id
    OG000
    title
    852A Treatment
population Description
Not able to analysis due to sale of agent - unable to perform.
reporting Status
POSTED
time Frame
Up to Week 12
title
Peak Concentrations of 852A
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice